AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis

AF1q is an MLL fusion partner that was identified from acute myeloid leukemia (AML) patients with t (1; 11) (q21; q23) chromosomal abnormality. The function of AF1q is not yet fully known, however, elevated AF1q expression is associated with poor clinical outcomes in various malignancies. Here, we s...

Full description

Bibliographic Details
Main Authors: Park, Jino, Schlederer, Michaela, Schreiber, Martin, Ice, Ryan, Merkel, Olaf, Bilban, Martin, Hofbauer, Sebastian, Kim, Soojin, Addison, Joseph, Zou, Jie, Ji, Chunyan, Bunting, Silvia T., Wang, Zhengqi, Shoham, Menachem, Huang, Gang, Bago-Horvath, Zsuzsanna, Gibson, Laura F., Rojanasakul, Yon, Remick, Scot, Ivanov, Alexey, Pugacheva, Elena, Bunting, Kevin D., Moriggl, Richard, Kenner, Lukas, Tse, William
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653036/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653036/

Similar Items